查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1779909

帕金森氏症深部腦部刺激療法的全球市場

Deep Brain Stimulation in Parkinson's Disease
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，巴金森氏症深部腦部刺激全球市場規模將達到 15 億美元

帕金森氏症深部腦部刺激全球市場規模預計在2024年達到8.825億美元，預計在分析期間（2024-2030年）將以8.7%的複合年成長率成長，到2030年將達到15億美元。雙通道深部腦部刺激是本報告分析的細分市場之一，預計其複合年成長率將達到10.2%，到分析期結束時達到9.538億美元。單通道深部腦部刺激細分市場在分析期間的複合年成長率預計為6.2%。

美國市場規模估計為 2.404 億美元，中國市場預計複合年成長率為 13.8%

預計到2024年，美國帕金森氏症深部腦部刺激市場規模將達2.404億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到3.222億美元，在2024-2030年的分析期間內，複合年成長率為13.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.3%和8.4%。在歐洲，預計德國市場的複合年成長率為5.8%。

帕金森氏症深部腦部刺激的全球市場—主要趨勢和促進因素摘要

深部腦部刺激是帕金森氏症治療的未來嗎？

深部腦部刺激 (DBS) 已成為帕金森氏症的突破性治療方法，為經歷運動波動和藥物難治症狀的患者帶來新希望。這種神經外科手術包括在大腦的特定區域植入電極並傳遞受控電脈衝來調節異常神經活動。多年來，DBS 技術取得了顯著發展，更新、更精確的系統改善了患者的預後。傳統的帕金森氏症藥物，如左旋多巴，通常會隨著時間的推移而變得不那麼有效，並導致使人衰弱的運動併發症。 DBS 提供了一種長期解決方案，可減少震顫、僵硬和運動障礙，並提高生活品質。微創手術技術和增強的即時神經影像學提高了 DBS 手術的安全性和準確性。此外，對自適應 DBS（根據大腦活動動態調整刺激水平）的研究為個人化治療策略打開了新的大門。

科技進步如何增強深部腦部刺激？

深部腦電刺激 (DBS) 技術的進步顯著提高了精準度、安全性和病患舒適度。可充電和相容 MRI 設備的引入延長了設備的使用壽命，並減少了頻繁更換的需求。閉合迴路DBS 系統基於神經反饋即時調整刺激參數，透過提供更個人化和高效的治療，正在徹底改變該領域。此外，人工智慧和機器學習正在整合到 DBS 編程中，使臨床醫生能夠以前所未有的精度最佳化刺激設定。無線編程和遠端監控功能的出現也簡化了術後管理，使神經科無需頻繁就診即可追蹤患者的病情進展。這些進步不僅改善了臨床療效，也支持 DBS 在更廣泛的患者群體中廣泛應用。

是什麼推動了帕金森氏症患者廣泛採用 DBS？

帕金森氏症患者病率的不斷上升，加上全球人口老化，推動了對深部腦電刺激 (DBS) 等先進治療方案的需求。隨著越來越多的臨床試驗檢驗了DBS 的長期有效性和安全性，醫生開始建議在病情發展早期進行手術，而不是將其作為最後的治療手段。患者對非藥物介入措施的認知度不斷提高，也有助於提高此療法的採用率。此外，手術機器人和電極置入技術的改進降低了手術相關風險，使其成為更廣泛患者的可行選擇。政府和醫療機構也逐漸認知到 DBS 的益處，從而加強了保險覆蓋範圍和報銷政策，使其成為一種經濟實惠的治療方法。

帕金森氏症深部腦部刺激市場的成長受到多種因素的推動...

深部腦電刺激 (DBS) 市場的成長受到多種因素的推動，包括技術的快速進步、帕金森氏症患者病率的上升以及人們對非侵入性長期治療方案日益成長的偏好。主導的閉合迴路刺激系統的發展提高了治療的精確度，使 DBS 能夠惠及更廣泛的患者。專科神經病學醫療基礎設施的擴展以及神經技術研究投入的增加也在市場擴張中發揮關鍵作用。此外，越來越多的監管部門核准和優惠的報銷政策正在鼓勵越來越多的醫院和診所採用 DBS 作為帕金森氏症的標準治療方法。個人化醫療的推動，即根據患者的獨特需求調整刺激參數，也是推動市場向前發展的主要因素。

部分

產品（雙通道深部腦部刺激、單通道深部腦部刺激）、最終使用者（醫院最終使用者、門診手術中心最終使用者、神經科科診所最終使用者、研究中心最終使用者）

受訪公司範例

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing Pinchi Medical Equipment Co., Ltd.
  • Beijing PINS Medical Co., Ltd.
  • Boston Scientific
  • BrainsWay Ltd.
  • DBS Technologies Pty Ltd
  • Epi-Minder
  • Fisher Wallace Laboratories
  • Flow Neuroscience
  • Functional Neuromodulation Ltd.
  • InBrain Neuroelectronics
  • Integer Holdings Corporation
  • LivaNova PLC
  • Medtronic
  • Neo-Bionica
  • Neuroelectrics
  • NeuroPace, Inc.
  • Pulsetto
  • Renishaw PLC

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP30395

Global Deep Brain Stimulation in Parkinson's Disease Market to Reach US$1.5 Billion by 2030

The global market for Deep Brain Stimulation in Parkinson's Disease estimated at US$882.5 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Dual-Channel Deep Brain Stimulation, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$953.8 Million by the end of the analysis period. Growth in the Single-Channel Deep Brain Stimulation segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$240.4 Million While China is Forecast to Grow at 13.8% CAGR

The Deep Brain Stimulation in Parkinson's Disease market in the U.S. is estimated at US$240.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$322.2 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Deep Brain Stimulation in Parkinson’s Disease Market - Key Trends & Drivers Summarized

Is Deep Brain Stimulation the Future of Parkinson’s Disease Treatment?

Deep Brain Stimulation (DBS) has emerged as a groundbreaking treatment for Parkinson’s disease, offering new hope to patients experiencing motor fluctuations and medication-resistant symptoms. This neurosurgical procedure involves implanting electrodes into specific brain regions, delivering controlled electrical impulses to modulate abnormal neural activity. Over the years, DBS technology has significantly evolved, with newer, more precise systems improving patient outcomes. Traditional pharmacological treatments for Parkinson’s disease, such as levodopa, often become less effective over time, leading to debilitating motor complications. DBS provides a long-term solution, reducing tremors, rigidity, and dyskinesia, thereby improving quality of life. The rise in minimally invasive surgical techniques and real-time neuroimaging has enhanced the safety and accuracy of DBS procedures. Additionally, research into adaptive DBS, which adjusts stimulation levels dynamically based on brain activity, is opening new doors for personalized treatment strategies.

How Are Technological Advancements Enhancing Deep Brain Stimulation?

Advancements in DBS technology have dramatically improved precision, safety, and patient comfort. The introduction of rechargeable and MRI-compatible implants has increased the longevity of devices, reducing the need for frequent replacements. Closed-loop DBS systems, which adjust stimulation parameters in real time based on neural feedback, are revolutionizing the field by providing more tailored and efficient treatment. Furthermore, AI and machine learning are being integrated into DBS programming, allowing physicians to optimize stimulation settings with unprecedented accuracy. The emergence of wireless programming and remote monitoring capabilities is also making post-surgical management more efficient, enabling neurologists to track patient progress without requiring frequent hospital visits. These advancements are not only enhancing clinical outcomes but also expanding the accessibility of DBS to a broader patient base.

What Is Driving the Growing Adoption of DBS in Parkinson’s Patients?

The increasing prevalence of Parkinson’s disease, coupled with an aging global population, is driving the demand for advanced treatment options like DBS. As more clinical trials validate the long-term efficacy and safety of DBS, physicians are recommending the procedure earlier in disease progression rather than as a last-resort treatment. The growing awareness among patients about non-pharmacological interventions has also contributed to higher adoption rates. Additionally, improvements in surgical robotics and electrode placement techniques have reduced the risks associated with the procedure, making it a more viable option for a wider range of patients. Governments and healthcare organizations are also recognizing the benefits of DBS, leading to increased insurance coverage and reimbursement policies that make the treatment more financially accessible.

The Growth in the Deep Brain Stimulation in Parkinson’s Disease Market Is Driven by Several Factors…

The growth in the DBS market is driven by several factors, including rapid technological advancements, the rising incidence of Parkinson’s disease, and an increasing preference for non-invasive, long-term treatment solutions. The development of AI-driven and closed-loop stimulation systems is enhancing treatment precision, making DBS more effective for a broader range of patients. The expansion of neurology-focused healthcare infrastructure and increasing investments in neurotechnology research are also playing a crucial role in market expansion. Furthermore, the rising number of regulatory approvals and favorable reimbursement policies are encouraging more hospitals and clinics to adopt DBS as a standard Parkinson’s treatment. The push toward personalized medicine, where stimulation parameters are adjusted based on patient-specific needs, is another major driver propelling the market forward.

SCOPE OF STUDY:

The report analyzes the Deep Brain Stimulation in Parkinson's Disease market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Dual-Channel Deep Brain Stimulation, Single-Channel Deep Brain Stimulation); End-Use (Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use, Research Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing Pinchi Medical Equipment Co., Ltd.
  • Beijing PINS Medical Co., Ltd.
  • Boston Scientific
  • BrainsWay Ltd.
  • DBS Technologies Pty Ltd
  • Epi-Minder
  • Fisher Wallace Laboratories
  • Flow Neuroscience
  • Functional Neuromodulation Ltd.
  • InBrain Neuroelectronics
  • Integer Holdings Corporation
  • LivaNova PLC
  • Medtronic
  • Neo-Bionica
  • Neuroelectrics
  • NeuroPace, Inc.
  • Pulsetto
  • Renishaw PLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Deep Brain Stimulation in Parkinson's Disease - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Parkinson's Disease Throws the Spotlight on Advanced Neuromodulation Therapies
    • Growing Patient Eligibility and Early Diagnosis Spur Demand for Deep Brain Stimulation (DBS) Interventions
    • Technological Advancements in Directional Leads and Closed-Loop Systems Strengthen the Business Case for DBS
    • Improved Battery Life and Rechargeable Implant Systems Enhance Patient Compliance and Quality of Life
    • Increasing Neurologist Awareness and Surgical Training Expand Accessibility to DBS Across Care Settings
    • FDA and CE Approvals of Next-Generation Devices Accelerate Market Penetration in Key Regions
    • Growing Evidence Base for DBS in Non-Motor Symptoms Propels Broader Use Across PD Patient Segments
    • Insurance Reimbursement and Coverage Expansion Support Affordability in Advanced Parkinson's Care
    • Adoption of MRI-Compatible Devices Reduces Risk and Facilitates Post-Surgical Monitoring
    • Wearable and App-Based Patient Tracking Tools Integrate with DBS Systems for Outcome Optimization
    • Minimally Invasive Surgical Techniques Reduce Recovery Time and Improve Patient Uptake
    • DBS Research in Younger-Onset Parkinson's and Genetic Cases Opens New Treatment Frontiers
    • Public-Private Research Initiatives Drive Investment and Innovation in Neuromodulation Platforms
    • Growing Global Burden of Neurological Disorders Supports Long-Term Growth in DBS Infrastructure
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Deep Brain Stimulation in Parkinson's Disease Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dual-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dual-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dual-Channel Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Single-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Single-Channel Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Single-Channel Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Neurology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Neurology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Neurology Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Deep Brain Stimulation in Parkinson's Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Deep Brain Stimulation in Parkinson's Disease by Product - Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by Product - Percentage Breakdown of Value Sales for Dual-Channel Deep Brain Stimulation and Single-Channel Deep Brain Stimulation for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Deep Brain Stimulation in Parkinson's Disease by End-Use - Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Deep Brain Stimulation in Parkinson's Disease by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgical Centers End-Use, Neurology Clinics End-Use and Research Centers End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION